RESUMO
Differential cross sections for Compton scattering from the proton have been measured at scattering angles of 55°, 90°, and 125° in the laboratory frame using quasimonoenergetic linearly (circularly) polarized photon beams with a weighted mean energy value of 83.4 MeV (81.3 MeV). These measurements were performed at the High Intensity Gamma-Ray Source facility at the Triangle Universities Nuclear Laboratory. The results are compared to previous measurements and are interpreted in the chiral effective field theory framework to extract the electromagnetic dipole polarizabilities of the proton, which gives α_{E1}^{p}=13.8±1.2_{stat}±0.1_{BSR}±0.3_{theo},ß_{M1}^{p}=0.2∓1.2_{stat}±0.1_{BSR}∓0.3_{theo} in units of 10^{-4} fm^{3}.
RESUMO
We report the first beam-target double-polarization asymmetries in the γ+n(p)âπ^{-}+p(p) reaction spanning the nucleon resonance region from invariant mass W=1500 to 2300 MeV. Circularly polarized photons and longitudinally polarized deuterons in solid hydrogen deuteride (HD) have been used with the CEBAF Large Acceptance Spectrometer (CLAS) at Jefferson Lab. The exclusive final state has been extracted using three very different analyses that show excellent agreement, and these have been used to deduce the E polarization observable for an effective neutron target. These results have been incorporated into new partial wave analyses and have led to significant revisions for several γnN^{*} resonance photocouplings.
RESUMO
Thirty-six Angus and Angus×Simmental heifers, averaging 291 kg, were used to determine the effects of dietary Cr, in the form of Cr propionate (Cr Prop), on glucose metabolism and serum insulin concentrations following glucose administration. Heifers were stratified by body weight (BW) within a breed and randomly assigned to treatments. Treatments consisted of 0, 3, 6, or 9 mg of supplemental Cr/d from Cr Prop. Based on dry matter (DM) intakes, the daily doses of Cr were equivalent to 0.47, 0.94, and 1.42 mg of supplemental Cr/kg of DM. Heifers were individually fed a corn silage-based diet at a level of 2% of BW. Each heifer was also fed 0.45 kg of a ground corn supplement daily that served as a carrier for supplemental Cr. Glucose tolerance tests were performed on d 44 of the study. Glucose was infused via jugular catheters at a level of 0.45 g/kg of BW(0.75) over a course of 1 to 2 min. Blood samples were collected at -10, 0, 5, 10, 15, 30, 45, 60, 90, 120, 150, and 180 min relative to glucose dosing for glucose and insulin determination. Area under the glucose response curve was lower (1,603 vs. 1,964 mg/dL per minute) in heifers supplemented with Cr from 0 to 45 min following glucose challenge. Serum insulin concentrations were lower in Cr-supplemented heifers than in controls following glucose infusion. The molar ratio of insulin to glucose was also lower in Cr-supplemented heifers relative to controls. Serum insulin and serum insulin to glucose ratios did not differ among heifers supplemented with 3, 6, or 9 mg of Cr/d. Results indicate that Cr Prop supplementation increased tissue sensitivity to insulin in growing heifers. Based on insulin sensitivity, Cr requirements (as Cr Prop) of growing heifers can be met by supplementing with 3 mg of Cr/d or 0.47 mg of Cr/kg of DM.
Assuntos
Bovinos/crescimento & desenvolvimento , Dieta/veterinária , Insulina/sangue , Propionatos/administração & dosagem , Animais , Glicemia/análise , Suplementos Nutricionais , Ácidos Graxos não Esterificados/sangue , Feminino , Glucose/administração & dosagem , Teste de Tolerância a Glucose , Zea maysRESUMO
The efficacy of several protocols for ovulation synchronization and timed artificial insemination (TAI) in goats was examined. In addition, the relationship between levels of pregnancy specific protein B (PSPB) during gestation assessed with a commercially available ELISA and the number of offspring at birth was determined. In Experiment 1, 70 does were randomized into four treatments: (1) breed by estrus [BBE], (2) 6-d treatment with a new [C6N], (3) once-used [C61], or (4) twice-used Controled Internal Drug Release (CIDR) device [C62)]. BBE does received two 15 mg doses of prostaglandin-F2α (PGF) at a 10-d interval and were bred 12 h after estrus onset. CIDR groups received a CIDR for 6 d with 15 mg PGF given at CIDR removal. TAI was performed 48 h after CIDR removal and does were given 50 µg GnRH. All does were inseminated with a single dose of frozen semen using a non-surgical, transcervical technique. Pregnancy rates for the BBE, C6N, C61 and C62 treatment groups were 39% ± 12%, 64% ± 12%, 77% ± 12% and 57% ± 12%, respectively, and did not differ. Reuse of CIDRs, even with reuse extending for a total of 21 d, was as effective as new CIDRs for synchronization of ovulation. In Experiment 2, 68 does were randomized into four treatments: (1) BBE, (2) C6N, (3) NC.Synch [NCS], (4) modified NCS [NCSM]. The BBE and C6N groups were as described for Experiment 1. The NCS and NCSM groups received 15 mg PGF on Day 1, 50 µg GnRH on Day 8 and 15 mg PGF on Day 15 (NCS) or Day 15.5 (NCSM). Does were bred by TAI at 72 h (NCS) or 60 h (NCSM) after the second PGF injection. All does in the NCS and NCSM groups received 50 µg GnRH at TAI. Pregnancy rates were 53% ± 12%, 30% ± 11%, 50% ± 11% and 41% ± 12% for does in the BBE, C6N, NCS and NCSM group, respectively, and did not differ. In Experiment 3, 62 does pregnant to TAI were bled at Days 48 and 85 post-insemination for PSPB. Data on kid numbers and birth weights were subsequently recorded. At Day 48 of gestation, PSPB levels for does birthing singletons were lower than for does birthing twins or triplets (25.0 ± 0.1a, 28.8 ± 0.1b and 30.7 ± 0b ng/mL, respectively, abP<0.05). At Day 85 of gestation, PSPB levels were progressively greater for does birthing singletons versus twins versus triplets (27.0 ± 0.1a, 28.5 ± 0.1b and 31.6 ± 0c ng/mL, abcP<0.05). In conclusion, PSPB concentrations detected using a commercially available ELISA at Day 48 or 85 of gestation could distinguish does carrying single versus multiple fetuses.
Assuntos
Sincronização do Estro/métodos , Cabras/fisiologia , Tamanho da Ninhada de Vivíparos , Ovulação/fisiologia , Glicoproteínas beta 1 Específicas da Gravidez/análise , Animais , Preparações de Ação Retardada , Dinoprosta/administração & dosagem , Sistemas de Liberação de Medicamentos/instrumentação , Ensaio de Imunoadsorção Enzimática/veterinária , Reutilização de Equipamento/veterinária , Feminino , Idade Gestacional , Cabras/sangue , Hormônio Liberador de Gonadotropina/administração & dosagem , Inseminação Artificial/métodos , Inseminação Artificial/veterinária , Gravidez , Resultado da Gravidez , Progesterona/administração & dosagemRESUMO
REASON FOR PERFORMING STUDY: Current therapy protocols to treat persistent post mating endometritis and retained fetal membranes in mares typically include the administration of ecbolic drugs. Evaluation of the pharmacokinetics and tolerability of carbetocin, a long-acting oxytocin analogue, after i.v. administration is required. OBJECTIVES: To determine the pharmacokinetic parameters (principally half-life) of carbetocin in horses. METHODS: Five mature mares and one gelding received 0.175 mg carbetocin i.v. All animals were monitored periodically throughout the study for elevation in rectal temperature, heart rate, respiratory rate and signs of pain or discomfort. Plasma samples were collected for determination of carbetocin concentrations by radioimmunoassay. RESULTS: Administration of carbetocin was well tolerated by all horses and its half-life was 17.2 min. CONCLUSIONS: The half-life of carbetocin is greater than that previously reported for oxytocin (6.8 min). POTENTIAL RELEVANCE: Carbetocin is an attractive alternative to oxytocin therapy in broodmare management.
Assuntos
Cavalos/sangue , Ocitocina/análogos & derivados , Animais , Área Sob a Curva , Feminino , Meia-Vida , Frequência Cardíaca/efeitos dos fármacos , Doenças dos Cavalos/sangue , Doenças dos Cavalos/tratamento farmacológico , Injeções Intravenosas/veterinária , Ocitocina/efeitos adversos , Ocitocina/farmacocinética , Ocitocina/uso terapêutico , Dor/induzido quimicamente , Dor/epidemiologia , Dor/veterinária , Radioimunoensaio/veterinária , Respiração/efeitos dos fármacosRESUMO
Beef Quality Assurance programs have contributed to significant improvements in the wholesomeness of beef available for consumption. Injection site blemishes in the round have declined since the promotion of administering intramuscular injections in the neck. Unfortunately, many producers continue to administer estrus synchronization (ES) drugs in the rump. The objective of this study was to compare the effectiveness of injection site of PGF2α, in ES protocols, on steroid hormone concentrations and pregnancy rates. A Select Synch + 7-day controlled internal drug release ES protocol was conducted with the site of PGF2α injection alternated between neck and rump in beef cattle (n = 312) at the Ohio State University Agricultural Technical Institute and North Carolina State University. Blood samples (n = 75) were collected at controlled internal drug release insertion and at the time of artificial insemination (AI) to determine if progesterone (P4) and estrogen (E2) concentrations varied due to PGF2α injection site. All cattle were confirmed pregnant by ultrasonography at approximately 30 and 90 days after insemination in North Carolina and approximately 70 days after insemination in Ohio. Data were analyzed as randomized complete block designs in PROC GLIMMIX with animal as the experimental unit. Differences were declared significant at P < 0.05. Site of PGF2α injection, in either the neck or rump, did not affect (P > 0.05) overall conception rates in response to AI (58.4% and 55.6%, respectively). Altering PGF2α injection site did not impact P4, E2 concentrations, or the P4:E2 ratio at AI (P > 0.05). However, cattle inseminated after displaying estrus had greater (P < 0.05) pregnancy rates than timed AI (67.8 vs. 47.5%, respectively). First service conception rates and pregnancy rates were consistent with previous reports. Overall, altering the location of the PGF2α injection during ES did not change circulating hormone concentrations at AI or pregnancy rates; therefore, cattle producers should follow Beef Quality Assurance guidelines when administering ES protocols.
Assuntos
Bovinos/fisiologia , Dinoprosta/farmacologia , Hormônio Liberador de Gonadotropina/farmacologia , Inseminação Artificial/veterinária , Progesterona/farmacologia , Animais , Dinoprosta/administração & dosagem , Esquema de Medicação , Detecção do Estro/instrumentação , Feminino , Hormônio Liberador de Gonadotropina/administração & dosagem , Gravidez , Fatores de TempoRESUMO
A study was conducted to examine the effects of low dietary Mn on growth performance of pregnant heifers and fetal development of their offspring. Twenty pregnant Angus (n = 9) and Simmental (n = 11) heifers averaging 17 mo of age and 447.6 kg of initial body weight were used in the 267-d study. Heifers were selected from a previous study examining the effects of supplemental Mn on growth and reproductive performance of heifers. Ten pregnant heifers per treatment from the control (analyzed at 15.8 mg of Mn/kg of DM) and supplemental Mn (50 mg/kg of DM) treatments were randomly selected at the conclusion of the previous study to continue on their respective dietary treatments through gestation and early lactation. Serum cholesterol for the 267-d period was not affected by treatment. Whole-blood Mn concentration of heifers on d 267 was not affected by treatment. Whole-blood Mn concentration at birth was lower in calves born to control heifers than in those born to supplemented heifers. Calves born to control heifers weighed less at birth than those born to heifers receiving supplemental Mn. Calves born to control heifers suffered from varying signs of Mn deficiency, including superior brachygnathism, unsteadiness, disproportionate dwarfism, and swollen joints. Results suggest that feeding gestating heifers a diet containing 16.6 mg of Mn/kg of DM is not adequate for proper fetal development. Supplementation of 50 mg of Mn/kg of DM to the control diet was sufficient to overcome any signs of Mn deficiency in calves.
Assuntos
Bovinos/fisiologia , Dieta/veterinária , Desenvolvimento Fetal/efeitos dos fármacos , Manganês/administração & dosagem , Ração Animal/análise , Animais , Peso Corporal/efeitos dos fármacos , Colesterol/sangue , Feminino , Desenvolvimento Fetal/fisiologia , Lactação , Manganês/sangue , Manganês/deficiência , GravidezRESUMO
The use of fixed-time artificial insemination (FTAI) provides producers with numerous benefits including the use of superior genetics, shorter breeding and calving seasons, and a more uniform calf crop. However, the cost of implementing FTAI protocols is one of the several drawbacks hindering their use in the beef industry. Potential injection-site lesions from intramuscular injections of the hormones necessary for estrus synchronization are also a cause of concern for carcass quality. The objectives of this experiment were to (1) determine whether or not a twice-used controlled internal drug release (CIDR) device would be effective in an FTAI protocol without adversely affecting pregnancy rate and (2) whether or not the subcutaneous administration of PGF2α affects pregnancy rate. Nulliparous females (n = 99) between 13 and 27 months of age and multiparous cows (n = 43) between 48 and 74 months of age were synchronized for estrus using the 7-day CO-Synch + CIDR protocol. The females were randomly assigned to one of the two treatments: (1) a once-used CIDR (control) or (2) a twice-used CIDR device (treatment) incorporated into their synchronization protocol. The females were also randomly assigned to have their injection of PGF2α administered either intramuscularly or subcutaneously. Blood was taken in a random subset of nulliparous females (n = 52) just before device removal and assayed for concentration of progesterone. The concentration of progesterone was higher (P = 0.01) in the animals that received once-used CIDR devices than that in those received twice-used CIDR devices (3.4 ± 0.5 and 1.4 ± 0.5 ng/mL, respectively). There was no significant effect of parity (P = 0.82), artificial insemination technician (P = 0.60), PGF2α administration (P = 0.83), or treatment (P = 0.67) on pregnancy rates to artificial insemination which were 75.4 ± 6.0% and 71.7 ± 6.4%, for animals that received once- and twice-used CIDR devices, respectively. This study provides evidence that although concentration of progesterone is decreased in animals treated with a twice-used CIDR device, there is still a sufficient release of progesterone from the device to effectively synchronize estrus without adversely affecting the fertility of a herd.
Assuntos
Bovinos/fisiologia , Dinoprosta/administração & dosagem , Sistemas de Liberação de Medicamentos/veterinária , Inseminação Artificial/veterinária , Taxa de Gravidez , Animais , Dinoprosta/efeitos adversos , Sistemas de Liberação de Medicamentos/instrumentação , Sincronização do Estro/métodos , Feminino , Qualidade dos Alimentos , Bombas de Infusão Implantáveis , Injeções Intramusculares/efeitos adversos , Inseminação Artificial/métodos , Gravidez , Progesterona/sangue , Carne VermelhaRESUMO
The hormone progesterone is essential for proper embryonic development. The objective of this study was to examine the relationship between recipient serum concentrations of progesterone, at the time of embryo transfer and at conceptus recovery, on conceptus development from in vivo- or in vitro-produced embryos. Embryos were produced in vivo by superovulation of Holstein cows (IVO; n = 17) or in vitro with either serum-containing (IVPS; n = 27) or serum-restricted medium (IVPSR; n = 34). Single grade I blastocysts from each embryo production system were transferred into heifers on day 7 of development. Conceptuses were recovered on day 17 of gestation and classified as complete, degenerated, or no conceptus. Compared with the IVO group, in vitro-produced embryos had more (P = 0.055) degenerated conceptuses (IVO, 0%; IVPS, 18.5%; and IVPSR, 20.6%). There were no differences in progesterone concentrations at the time of transfer when recipients received either male or female embryos (P > 0.05). Progesterone concentrations in recipients receiving in vivo-produced embryos were higher (P < 0.05; 3.74 ± 0.4 ng/mL; least-squares mean ± standard error of the mean) on day 7 compared with those receiving in vitro-produced embryos (IVPS, 2.4 ± 0.2; IVPSR, 2.58 ± 0.3 ng/mL). However, there was no difference in progesterone concentration on day 7 between treatment groups for heifers from which short conceptuses (≤194 mm) were recovered on day 17. In contrast, when longer (>194 mm) conceptuses were recovered on day 17, heifers receiving in vitro-produced embryos had lower (P = 0.05) serum concentrations of progesterone on day 7 compared with those receiving in vivo-produced embryos (IVPS, 2.2 ± 0.5; IVPSR, 2.3 ± 0.5; IVO, 3.9 ± 0.5 ng/mL). In conclusion, differences in autonomy may exist between in vitro- and in vivo-produced embryos during the period of conceptus elongation with in vitro-produced embryos relying more on intrinsic factors to influence elongation.
Assuntos
Bovinos/embriologia , Desenvolvimento Embrionário/fisiologia , Fertilização in vitro/veterinária , Progesterona/sangue , Animais , Blastocisto/fisiologia , Transferência Embrionária/veterinária , Feminino , Idade Gestacional , Masculino , Gravidez , SuperovulaçãoRESUMO
This study examined the role of two dopaminergic (DA) cell groups, the A-14 and A-15 DA groups, in the seasonal shift in the response of LH to estradiol negative feedback in ewes. Radiofrequency lesions were placed bilaterally, in the area of the A-15 or the ventromedial A-14 cell groups of ovariectomized ewes, while control animals underwent sham neurosurgery. The effect of estrogen was tested in anestrus by analyzing LH pulse patterns before and 3 and 10 days after the insertion of estradiol implants. To evaluate the effects of these lesions on DA inhibition of LH secretion, LH pulse patterns were compared before and after an iv injection of the DA antagonist pimozide on day 3 of estradiol treatment. LH pulses were also examined in these ewes during the breeding season before and 3 days after the insertion of estradiol implants. Also, the effect of the DA receptor agonist apomorphine was tested to determine any effect of lesions on DA receptors inhibitory to LH. Lesions in either the A-14 or A-15 area decreased, but did not completely abolish, estradiol inhibition of LH pulse frequency in anestrus. Both types of lesions also blocked the stimulatory effects of pimozide on LH pulse frequency in estradiol-treated ovariectomized anestrous ewes. During the breeding season, estrogen decreased LH pulse amplitude, but not frequency, in all groups. The DA receptor agonist apomorphine decreased LH pulse frequency in all groups. Furthermore, immunohistochemistry for tyrosine hydroxylase revealed catecholaminergic fibers apparently connecting the caudal A-14 and the rostral A-15 areas. These results suggest that both the A-14 and A-15 DA cell groups are involved in the inhibition of LH by estradiol in anestrous, but not breeding season, ewes. Seasonal shifts in the activity of these DA neurons may, thus, play a role in the annual reproductive cycle of the ewe.
Assuntos
Anestro/fisiologia , Dopamina/fisiologia , Estradiol/fisiologia , Hipotálamo/fisiologia , Animais , Apomorfina/farmacologia , Retroalimentação , Feminino , Hipotálamo/enzimologia , Hormônio Luteinizante/metabolismo , Neurônios/enzimologia , Ovariectomia , Pimozida/farmacologia , Prolactina/sangue , Reprodução , Ovinos , Tiroxina/sangue , Tirosina 3-Mono-Oxigenase/metabolismoRESUMO
The effects of intracerebroventricular (icv) administration of porcine corticotropin-releasing hormone (pCRH) and cortisol on the immune system and behavior were examined in domestic pigs. In Experiment 1, 50 micrograms of pCRH in 200 microliters of saline or 200 microliters of vehicle was administered i.c.v. at 0600 h. Blood samples were obtained at 0600 (prior to injection), 0700, and 0800 h. Plasma cortisol concentrations were higher at 1 and 2 h after pCRH than after saline. Generally, pCRH failed to effect NK cytotoxicity or lymphocyte proliferation in response to phytohemagluttin (PHA). However, 1 h postinjection, pigs administered pCRH i.c.v. had marginally lower NK activity than control pigs. Pigs injected with pCRH had substantially lower neutrophil chemotaxis (CHTX) than the control pigs at 1 and 2 h postinjection. As blood cortisol concentration increased, neutrophil CHTX decreased. Pigs injected i.c.v. with pCRH had higher neutrophil numbers and neutrophil:lymphocyte ratios than control pigs. Percentage of lymphocytes was higher among control than treated pigs. Central pCRH increased overall activity, particularly walking, standing, licking, rooting, and increased activity-related sequences (e.g., sit, walk and stand, walk), but reduced complex oral/nasal sequences (e.g., root, lick). In Experiment 2, pigs were injected i.c.v. with 10 micrograms of cortisol in 200 microliters of saline or with vehicle at 0600 h. Administration of cortisol failed to effect NK cytotoxicity, lymphocyte proliferation, CHTX, or leukocyte distribution. Pigs given cortisol had no apparent change in behavior. These data indicate leukocyte distribution and specific neutrophil function in pigs were significantly modulated by stress-related hormones of the hypothalamic-pituitary-adrenal axis and complexity of behavioral sequences (pigs repeating certain behavioral sequences) associated with increased activity was reduced. Oral/nasal stereotypies (as seen among confined sows) were not elevated among pigs given i.c.v. pCRH. CRH given by i.c.v. administration may serve as a better model for acute rather than chronic stress.
Assuntos
Hormônio Liberador da Corticotropina/fisiologia , Citotoxicidade Imunológica/imunologia , Hidrocortisona/fisiologia , Sistema Hipotálamo-Hipofisário/fisiologia , Células Matadoras Naturais/imunologia , Atividade Motora/fisiologia , Sistema Hipófise-Suprarrenal/fisiologia , Comportamento Estereotipado/fisiologia , Animais , Nível de Alerta/fisiologia , Quimiotaxia de Leucócito/imunologia , Ativação Linfocitária/imunologia , Masculino , Neutrófilos/imunologia , SuínosRESUMO
Three experiments were performed to determined the effect of anterior hypothalamic deafferentation (AHD) on the inhibitory actions of estradiol and progesterone on luteinizing hormone (LH) pulse frequency in ovariectomized ewes during the anestrous season. The first experiment tested the effects of AHD on LH secretion in the absence of gonadal steroids. AHD was accomplished by a 180 degree knife cut (Halasz knife) placed at the posterior border of the optic chiasm (n = 4). Control ewes received sham cuts or no surgery (n = 6). LH pulses were monitored in blood samples taken every 12 min for 4 hr before and after surgery. AHD reduced LH pulse amplitude (pre 7.4 +/- 2.9 ng/ml; post 1.2 +/- 0.3 ng/ml), but had no effect on LH pulse frequency (pre 3.5 +/- 0.3/4 hr; post 3.3 +/- 0.3/4 hr) in ovariectomized ewes. In the second experiment all ewes were given a Silastic implant containing estradiol (1 cm long) and 2 d later bled at 12 min intervals for 4 hr before and after administration of pimozide (PIM, 0.08 mg/kg), a dopamine antagonist. Estradiol decreased LH pulse frequency in controls (2.8 +/- 0.4 to 1.5 +/- 0.3/4 hr) and this was reversed by PIM (2.5 +/- 0.4/4 hr). In contrast, estradiol did not decrease pulse frequency in AHD ewes (3.3 +/- 0.3 to 2.8 +/- 0.5/4 hr) and PIM did not increase it (2.7 +/- 0.7/4 hr). In the third experiment, all ewes were given Silastic implants containing progesterone.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Estradiol/farmacologia , Hipotálamo Anterior/fisiologia , Hormônio Luteinizante/metabolismo , Progesterona/farmacologia , Ovinos/fisiologia , Anestro , Animais , Denervação , Retroalimentação , Feminino , Hipotálamo Anterior/cirurgia , Ovariectomia , Periodicidade , Pimozida/farmacologiaRESUMO
Ovariectomized gilts were either placed on full feed (FF) or restricted to one-third of the full feed amount (RST) for 7 days. Blood samples were taken through jugular catheters every 15 min for 4 h at the end of the 7-day period. Then dietary treatments were reversed and 7 days later samples were taken as before. Serum concentrations of leptin, insulin and luteinizing hormone (LH) were determined by radioimmunoassay. LH pulse frequency and mean serum leptin and insulin concentrations were lower (P < 0.01) in RST than FF gilts. Reversal of treatment reversed the patterns of hormone secretion. These results confirm previous observations that feed restriction can inhibit pulsatile LH secretion and also decrease leptin and insulin secretion.
Assuntos
Privação de Alimentos , Insulina/sangue , Leptina/sangue , Hormônio Luteinizante/sangue , Ovariectomia , Suínos/sangue , Animais , Feminino , Alimentos , PeriodicidadeRESUMO
Manipulation of one ovary in prepubertal gilts treated with pregnant mare serum gonadotropin (PMSG) and human chorionic gonadotropin (hCG) results in cysts on the manipulated ovary and corpora lutea (CL) on the non-manipulated (control) ovary. Because tissue-type plasminogen activator (tPA) might play a role in follicular rupture and because relaxin might increase tPA production, concentrations of tPA and relaxin in manipulated and control follicles were measured at different stages of development. Prepubertal gilts were treated with 1000 IU PMSG followed by 750 IU hCG at 72 hr later. Follicles on one ovary in each gilt were manipulated at laparotomy 48 hr after PMSG administration. Gilts were ovariectomized at 72, 90, 108, 114, 144, and 216 hr after PMSG. Concentrations of tPA and relaxin were determined for follicular fluid from follicles dissected free of ovarian stroma and snap frozen in liquid nitrogen and media from follicles cultured for 48 hr. Relaxin did not differ between treatment groups (manipulated and control) at any time (P > 0.05); whereas, tPA was greater in control follicles at 114 hr after PMSG than in manipulated follicles (P < 0.01). The effect of pyrilamine, a histamine-1 receptor antagonist, on tPA concentrations was determined in manipulated and control follicles collected at 3, 12, 24, 42, and 66 hr after manipulation. Concentrations of tPA were similar in control and manipulated follicles for gilts treated with pyrilamine, but again control follicles had greater (P < 0.05) tPA concentrations at 114 hr after PMSG. Thus, tPA seems to be involved in ovulation, and blockage of ovulation and subsequent cyst formation results from inadequate tPA activity in manipulated follicles.
Assuntos
Cistos Ovarianos/veterinária , Folículo Ovariano/metabolismo , Relaxina/metabolismo , Doenças dos Suínos/metabolismo , Suínos/fisiologia , Ativador de Plasminogênio Tecidual/metabolismo , Animais , Meios de Cultura , Ensaio de Imunoadsorção Enzimática/veterinária , Feminino , Líquido Folicular/química , Antagonistas dos Receptores Histamínicos H1/farmacologia , Laparotomia/veterinária , Cistos Ovarianos/metabolismo , Ovariectomia/veterinária , Pirilamina/farmacologia , Radioimunoensaio/veterinária , Distribuição Aleatória , Relaxina/análise , Ativador de Plasminogênio Tecidual/análiseRESUMO
Three distinct waves of Leydig cell development are found in the pig testes, which occur during fetal, perinatal, and prepubertal periods. Proliferation of Leydig cells is primarily regulated by luteinizing hormone (LH); however, effects of LH on proliferation of immature rat Leydig cells are mediated by specific growth factors and cytokines such as transforming growth factor-alpha (TGFalpha), insulin-like growth factor-1 (IGF-1), interleukin-1beta (IL-1beta), steroidogenesis-inducing protein (SIP), and TGFbeta. The objective of the present study was to identify growth factors that could possibly be involved in the proliferation of Leydig cells in the neonatal pig testis. Leydig cells were isolated from 3- to 5-d-old pig testes, cultured for 48 hr in serum-free media, washed, and treated with hCG and/or IGF-1, epidermal growth factor (EGF), IL-1beta, SIP, and TGFbeta for 18 hr. Tritiated thymidine incorporation into DNA was assessed over a subsequent 4-hr period. Incorporation of [3H]-thymidine was stimulated by hCG treatment with a 2.3-fold increase over control cultures. SIP also induced a significant increase (P < 0.0001) in the incorporation of [3H]thymidine into Leydig cell DNA. Similarly, EGF and IGF-1 also increased DNA synthesis in neonatal porcine Leydig cells, whereas IL-1beta had no effect. TGFbeta had very little, if any, effect on DNA synthesis when added alone, but inhibited the stimulatory effects of other mitogens (SIP, hCG, EGF/TGFalpha, and IGF-1). Our results indicate that these growth factors may play a role in the LH/hCG-dependent proliferation of Leydig cells during the perinatal period of development.
Assuntos
Replicação do DNA , Regulação da Expressão Gênica , Proteínas de Choque Térmico , Células Intersticiais do Testículo/metabolismo , Chaperonas Moleculares , Suínos/metabolismo , Animais , Animais Recém-Nascidos , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Gonadotropina Coriônica/fisiologia , Replicação do DNA/efeitos dos fármacos , Fator de Crescimento Epidérmico/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Interleucina-1/farmacologia , Células Intersticiais do Testículo/efeitos dos fármacos , Hormônio Luteinizante/fisiologia , Masculino , Proteínas/farmacologia , Ratos , Timidina/metabolismo , Fator de Crescimento Transformador alfa/farmacologiaRESUMO
The objective of this study was to determine the effects of monensin (M) and altered forage:concentrate ratio (F:C) on feed intake, hormonal profiles, and ovarian function in beef heifers. Four ruminally cannulated heifers were maintained in metabolism crates and fed twice daily. Diets contained 0 or 200mg per day M in diets of 70:30 (high forage, HF) or 30:70 (high concentrate, HC) F:C. Diets were limit fed to achieve isocaloric intake of calculated ME. Monensin supplementation had no effect on feed intake, but heifers fed HF had greater refusals compared with heifers fed HC (P<0.005). Serum insulin, progesterone, and estradiol concentrations did not differ between diets or treatments (P>0.10). Diet and/or treatment tended to alter the size or number of follicles on either or both ovaries. Monensin resulted in more waves of follicular development per estrous cycle with HF diets, but fewer with HC diets (P<0.07). The interovulatory interval, lifespan of the corpus luteum, and the size of the dominant follicle in the first two follicular waves were not different due to diet or treatment. However, the HC diet tended to produce a larger ovulatory follicle compared with the HF diet (HF=12.25, HC=13.5; P<0.08). We conclude that feeding monensin affects estradiol secretion and a higher proportion of concentrates alters ovarian dynamics, which could affect fertility in beef heifers.
Assuntos
Antiprotozoários/farmacologia , Bovinos/fisiologia , Ingestão de Alimentos/efeitos dos fármacos , Hormônios/sangue , Monensin/farmacologia , Ovário/efeitos dos fármacos , Animais , Dieta , Estradiol/sangue , Feminino , Insulina/sangue , Ovário/fisiologia , Progesterona/sangueRESUMO
Chronic undernutrition results in reduced secretion of luteinizing hormone (LH). Two experiments were conducted in wethers whose LH secretion was suppressed by growth restriction caused by feeding a maintenance ration. The first study examined neurotransmitters that may be actively inhibiting LH secretion during growth restriction. The effects of various neurotransmitter antagonists were investigated: pimozide (PIM, dopamine), cyproheptadine (CYP, serotonin), pyrilamine (PYR, H1), cimetidine (CMT, H2) and propranolol (PRO, beta-adrenergic) in wethers specifically fed to maintain a body weight of 28 kg (GR, n = 7) and in full fed control wethers (n = 5). Blood samples were taken at 15 min intervals for 4 h before and after drug administration. Serum LH concentrations were determined by radioimmunoassay (RIA). Only PIM increased (P < 0.01) serum LH pulse frequency in the GR wethers (pre 0.5 +/- 0.2 pulses per 4 h vs. post 2.6 +/- 0.9 pulses per 4 h). None of the drugs tested had an effect on the control wethers. Experiment 2 examined the effect of glucose administration (50, 100, or 150 mg i.v.) on LH secretion in GR wethers. Only the 150 mg dose significantly (P < 0.05) increased LH pulse frequency compared to the pre-injection period (1.1 +/- 0.3 vs. 2.0 +/- 0.4 pulses per 4 h). After refeeding, LH pulse frequency and serum glucose concentrations increased. Proglumide, a cholecystokinin (CCK) antagonist, did not block this increase (2.1 +/- 0.4 vs. 2.2 +/- 0.3 pulses per 4 h). These data suggest that dopamine inhibits LH secretion in GR wethers and that increasing serum glucose concentrations increased LH secretion.
Assuntos
Glucose/farmacologia , Hormônio Luteinizante/metabolismo , Neurotransmissores/antagonistas & inibidores , Ovinos/fisiologia , Animais , Cimetidina/farmacologia , Ciproeptadina/farmacologia , Privação de Alimentos/fisiologia , Glucose/fisiologia , Masculino , Neurotransmissores/fisiologia , Pimozida/farmacologia , Propranolol/farmacologia , Pirilamina/farmacologia , Ovinos/crescimento & desenvolvimentoRESUMO
Two trials were designed to test whether a single treatment with a microsphere formulation of progesterone (P) could simulate the luteal phase of the estrous cycle and lead to estrus and subsequent luteal development. The first experiment was to characterize the pattern of serum P concentrations and estrus in cows treated with a microsphere formulation (P + E) that contained 625 mg P and 50 mg estradiol (E). Four cows with palpable corpora lutea were treated with 25 mg prostaglandin F2 m. Each cow was given P + E (i.m.) 12 h later. Tail vein blood samples were taken on Days 1 and 2 following P + E treatment and then three times weekly for 24 days. Serum P increased from 0.8 +/- 0.1 ng/ml at P + E treatment to 4.7 +/- 0.6 ng/ml on Day 1, declined gradually to 4.1 +/- 0.3 ng/ml on Day 7 and then declined more rapidly to 0.6 +/- 0.1 ng/ml on Day 13. Treated cows showed estrus 16.25 +/- 0.7 days after P + E treatment. Thereafter, serum P increased beginning on Day 20 after P + E treatment, as expected following estrus. In Experiment 2, Angus and Simmental heifers (10.5-11.5 months of age) were administered i.m. either the vehicle (controls), E (50 mg), P (625 mg) or P + E (n = 13 per group). While treatment with E resulted in behavioral estrus (1-2 days after treatment) in each treated heifer, it did not (P > 0.5) initiate estrous cycles as indicated by subsequent increased serum P. In contrast, the P and P + E treatments increased (P < 0.05) the proportion (11/13) of heifers that showed estrus by 21 days after treatment followed by elevated serum P. We conclude that the microsphere formulation of P simulated the pattern of serum P concentrations during the luteal phase of the estrous cycle and initiated estrous cycles in peripubertal heifers with or without E.
Assuntos
Bovinos/fisiologia , Estradiol/administração & dosagem , Estro/efeitos dos fármacos , Microesferas , Progesterona/administração & dosagem , Maturidade Sexual/efeitos dos fármacos , Animais , Dinoprosta/administração & dosagem , Feminino , Ovulação/efeitos dos fármacos , Progesterona/sangueRESUMO
Serum luteinizing hormone (LH) and cortisol concentrations were measured in ten fall calving, Angus cows averaging 38 +/- 8 days postpartum. Calves from five cows were weaned at the beginning of the study. Blood samples were collected at 20 min. intervals for 48 h after weaning and for 8 h on day 4 and day 6 postweaning. Mean serum LH concentrations increased (P<0.01) in weaned cows (W) from 0.55 +/- 0.01 ng/ml at time of calf removal to 1.3 +/- 0.04 ng/ml 48 h afterwards. Comparable LH concentrations for suckled cows (S) were 0.65 +/- 0.08 ng/ml and 0.62 +/- 0.03 ng/ml respectively. Average serum LH concentrations at 48 h after weaning were greater (P<0.01) for W cows than S cows and a treatment by time interaction occurred (P<0.01) with serum LH concentrations increasing (P<0.01) from time of calf removal to 48 h after calf removal in W cows. Frequency of LH peaks increased (P<0.01) in W cows and by 48 h after weaning was greater (P<0.01) in W cows than in S cows. Magnitude of LH peaks did not differ between the two groups. Serum cortisol concentrations were not different between W and S cows except for a transient elevation (P<0.01) in W cows from 7.6 +/- 0.9 ng/ml to 11.9 +/- 1.0 ng/ml 9 to 12 h after calf removal. Since serum LH concentrations were increased in W cows but not in S cows at 48 h and serum cortisol concentrations increased transiently in W cows we suggest that circulating cortisol levels may not be a physiological inhibitor of LH secretion in the suckled postpartum beef cow.
RESUMO
This study was conducted to determine proopiomelanocortin (POMC) mRNA levels in the preoptic and hypothalamic brain regions of postpartum anestrous cows. An additional objective was to determine if calf suckling influences POMC mRNA concentration in these regions. Twenty cows were randomly assigned to suckled and nonsuckled treatment groups and slaughtered between 30 and 36 days postpartum. Serum luteinizing hormone (LH) concentrations were determined from blood collected every 15 minutes for 8 hours, starting 20 hours prior to slaughter. POMC mRNA levels in brain tissues were determined by dot blots. Serum LH concentrations between nonsuckled and suckled cows were 1.3 +/- 0.2 and 0.9 +/- 0.1 ng.ml(-1) (mean +/- SEM; P = 0.19), respectively. The POMC gene is expressed in the hypothalamus of postpartum anestrus cows with POMC mRNA levels higher (P<0.05) in the hypothalamus than in the preoptic region. Hypothalamic POMC mRNA levels tended (P = 0.12) to be lower in nonsuckled (14.9 +/- 3.8 ADU) than in suckled cows (23.5 +/- 3.6 ADU). Covariate analysis indicated (P = 0.10) that as mean serum LH concentrations increased, hypothalamic POMC mRNA levels decreased.